Zilong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zilong Zhang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Feifei Cui
Hainan University
5 shared publications - Qingchen Zhang
Hainan University
3 shared publications - Quan Zou
Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China
3 shared publications Leyi Wei
Centre for Artificial Intelligence driven Drug Discovery, Faculty of Applied Science, Macao Polytechnic University, Macao, China
2 shared publicationsShun Gao
School of Computer Science and Technology, Hainan University, Haikou, China
2 shared publications- Buchao Zhan
School of Computer Science and Technology, Hainan University, Hainan, 570228, China
1 shared publication
Latest Publications
- 23 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 23 (1) , 419-431
DeepR2OM: Accurate Recognition for RNA 2′-O-Methylation Sites in Human Genome Using Deep Learning
2'-O-methylation (2OM) of ribose is a widespread RNA modification that significantly impacts RNA stability, structure, and function. Accurately predicting 2OM sites is crucial for understanding RNA's biological functions and related pathologies. Traditional detection methods pose challenges such as resource intensiveness, potential RNA sample damage, and high costs. However, recent advancements in machine learning, particularly deep learning techniques, offer rapid and cost-effective prediction solutions. In this study, we introduce DeepR2OM, a novel method integrating feature selection and deep learning for 2OM sites prediction. DeepR2OM encodes sequences using eight RNA descriptors, employs feature selection algorithms to reduce dimensions, and then utilizes a deep learning network for training. After evaluating various deep learning architectures, we selected Convolutional Neural Network (CNN), Multi-Head Self-Attention mechanism, and Deep Neural Network (DNN) as our final prediction models. Experimental results demonstrate DeepR2OM's effectiveness, achieving 87.1% accuracy (ACC), 85.5% recall rate (Recall), 87.9% precision (PRE), and a Matthews correlation coefficient (MCC) of 75.7% on an independent test set. This tool serves as a valuable resource for exploring the functional and bioinformatic aspects of 2OM sites. To enhance accessibility, we have developed a web server for the prediction of RNA 2'-O-Methylation
- 23 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 23 (1) , 419-431
DeepR2OM: Accurate Recognition for RNA 2′-O-Methylation Sites in Human Genome Using Deep Learning
2'-O-methylation (2OM) of ribose is a widespread RNA modification that significantly impacts RNA stability, structure, and function. Accurately predicting 2OM sites is crucial for understanding RNA's biological functions and related pathologies. Traditional detection methods pose challenges such as resource intensiveness, potential RNA sample damage, and high costs. However, recent advancements in machine learning, particularly deep learning techniques, offer rapid and cost-effective prediction solutions. In this study, we introduce DeepR2OM, a novel method integrating feature selection and deep learning for 2OM sites prediction. DeepR2OM encodes sequences using eight RNA descriptors, employs feature selection algorithms to reduce dimensions, and then utilizes a deep learning network for training. After evaluating various deep learning architectures, we selected Convolutional Neural Network (CNN), Multi-Head Self-Attention mechanism, and Deep Neural Network (DNN) as our final prediction models. Experimental results demonstrate DeepR2OM's effectiveness, achieving 87.1% accuracy (ACC), 85.5% recall rate (Recall), 87.9% precision (PRE), and a Matthews correlation coefficient (MCC) of 75.7% on an independent test set. This tool serves as a valuable resource for exploring the functional and bioinformatic aspects of 2OM sites. To enhance accessibility, we have developed a web server for the prediction of RNA 2'-O-Methylation
- 11 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 23 (1) , 362-373
A Multi-Modal Contrastive Learning Framework for Cyclic Peptide Permeability Prediction
Cyclic peptides represent a rapidly growing class of therapeutics, yet their development is often hindered by the challenge of predicting cell membrane permeability, a critical determinant of drug efficacy. Existing computational methods often struggle to integrate the diverse structural information inherent in these complex molecules, resulting in suboptimal predictive accuracy. Here, we introduce MCPerm, a multi-modal deep learning framework that synergistically integrates 1D SMILES, 2D topological, and 3D geometric information through a novel modality share and contrastive learning strategy to accurately predict cyclic peptide permeability. MCPerm fine-tunes a pretrained peptide language model for SMILES encoding and uses a parameter-sharing graph transformer for structural representation, while a dual contrastive learning mechanism enforces representational consistency both within and between modalities. On the benchmark PAMPA dataset, MCPerm achieves state-of-the-art performance, significantly outperforming leading methods. We further demonstrate its robustness and competitive transferability across three independent assays (Caco-2, MDCK, and RRCK). Our work presents a robust in silico framework that holds potential to accelerate the rational design and discovery of cell-permeable cyclic peptide drugs. Furthermore, to move beyond predictive accuracy, we introduced an attention-based visualization analysis. The results demonstrate that our model is not a “black box”; it has learned key chemical principles governing cyclic peptide permeability.
- 11 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 23 (1) , 362-373
A Multi-Modal Contrastive Learning Framework for Cyclic Peptide Permeability Prediction
Cyclic peptides represent a rapidly growing class of therapeutics, yet their development is often hindered by the challenge of predicting cell membrane permeability, a critical determinant of drug efficacy. Existing computational methods often struggle to integrate the diverse structural information inherent in these complex molecules, resulting in suboptimal predictive accuracy. Here, we introduce MCPerm, a multi-modal deep learning framework that synergistically integrates 1D SMILES, 2D topological, and 3D geometric information through a novel modality share and contrastive learning strategy to accurately predict cyclic peptide permeability. MCPerm fine-tunes a pretrained peptide language model for SMILES encoding and uses a parameter-sharing graph transformer for structural representation, while a dual contrastive learning mechanism enforces representational consistency both within and between modalities. On the benchmark PAMPA dataset, MCPerm achieves state-of-the-art performance, significantly outperforming leading methods. We further demonstrate its robustness and competitive transferability across three independent assays (Caco-2, MDCK, and RRCK). Our work presents a robust in silico framework that holds potential to accelerate the rational design and discovery of cell-permeable cyclic peptide drugs. Furthermore, to move beyond predictive accuracy, we introduced an attention-based visualization analysis. The results demonstrate that our model is not a “black box”; it has learned key chemical principles governing cyclic peptide permeability.
- 3 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 23 (1) , 247-258
FNatPred: A Data-Driven Approach for Distinguishing Between NAT and Tumor on the Fungal Microbiome
Objective: The role of fungal microbiota in human carcinogenesis remains largely uncharacterized. Recent evidence suggests normal adjacent tissue (NAT) represents an intermediate state between healthy and malignant tissues, highlighting its potential for early cancer detection. Discriminating fungal compositional profiles between tumor and NAT is thus critical for elucidating fungal involvement in oncogenesis. However, the high similarity between tumor and NAT mycobiota poses significant analytical challenges. Method: To overcome this limitation, we developed a two-level ensemble discriminative model. Base-level classifiers, trained using rigorously filtered fungal microbiota data (based on prevalence, abundance, and quality metrics) via Random Forest, generate initial predictions. A meta-level classifier then integrates these base predictions, transforming high-dimensional, sparse fungal feature data into a low-dimensional, dense representation optimized for discrimination. Model implementation and analysis code are available at: https://github.com/cskyan/FNatPred. Results: Our approach achieved clear separation between tumor and NAT mycobiomes across multiple cancer types, with particularly pronounced discrimination in colorectal cancer (CRC). The proposed model significantly outperformed existing methods in tumor-NAT classification, demonstrating an average AUC improvement of approximately 10%.
- 3 December 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 23 (1) , 247-258
FNatPred: A Data-Driven Approach for Distinguishing Between NAT and Tumor on the Fungal Microbiome
Objective: The role of fungal microbiota in human carcinogenesis remains largely uncharacterized. Recent evidence suggests normal adjacent tissue (NAT) represents an intermediate state between healthy and malignant tissues, highlighting its potential for early cancer detection. Discriminating fungal compositional profiles between tumor and NAT is thus critical for elucidating fungal involvement in oncogenesis. However, the high similarity between tumor and NAT mycobiota poses significant analytical challenges. Method: To overcome this limitation, we developed a two-level ensemble discriminative model. Base-level classifiers, trained using rigorously filtered fungal microbiota data (based on prevalence, abundance, and quality metrics) via Random Forest, generate initial predictions. A meta-level classifier then integrates these base predictions, transforming high-dimensional, sparse fungal feature data into a low-dimensional, dense representation optimized for discrimination. Model implementation and analysis code are available at: https://github.com/cskyan/FNatPred. Results: Our approach achieved clear separation between tumor and NAT mycobiomes across multiple cancer types, with particularly pronounced discrimination in colorectal cancer (CRC). The proposed model significantly outperformed existing methods in tumor-NAT classification, demonstrating an average AUC improvement of approximately 10%.
- 7 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (2) , 1746-1758
FusionMVSA: Multi-View Fusion Strategy With Self-Attention for Enhancing Drug Recommendation
Leveraging the wealth of biomedical data available, we can derive insights into the relationships between biological entities from various angles. This underscores the complexity and significance of developing a dynamic approach for integrating data from multiple sources, a critical endeavor in drug recommendation. In this study, we introduce an innovative deep learning approach termed “Multi-View Fusion Strategy with Self-Attention” (FusionMVSA), designed to predict associations between drugs and diseases. To effectively amalgamate data from diverse sources and extract representative features, we have developed a feature extraction mechanism that capitalizes on similarities. This mechanism computes self-attention across multiple perspectives using shared group parameters, thereby highlighting common characteristics. Simultaneously, we utilize biomedical similarities among multi-source data as guiding factors for calculating similarity, enabling the capture of more nuanced features. Subsequently, we integrate these features through a feature fusion process, where known associations between drugs and diseases act as guiding terms. This strategy allows us to uncover the complementary aspects of different viewpoints. Ultimately, we predict potential drug-disease associations using a multi-layer perceptron neural network. Our methodology has undergone rigorous testing through various cross-validation experiments and case studies. We are confident that FusionMVSA will prove to be a valuable tool in drug recommendation, offering new avenues for exploration and discovery in the quest to combat diseases.
- 7 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (2) , 1746-1758
FusionMVSA: Multi-View Fusion Strategy With Self-Attention for Enhancing Drug Recommendation
Leveraging the wealth of biomedical data available, we can derive insights into the relationships between biological entities from various angles. This underscores the complexity and significance of developing a dynamic approach for integrating data from multiple sources, a critical endeavor in drug recommendation. In this study, we introduce an innovative deep learning approach termed “Multi-View Fusion Strategy with Self-Attention” (FusionMVSA), designed to predict associations between drugs and diseases. To effectively amalgamate data from diverse sources and extract representative features, we have developed a feature extraction mechanism that capitalizes on similarities. This mechanism computes self-attention across multiple perspectives using shared group parameters, thereby highlighting common characteristics. Simultaneously, we utilize biomedical similarities among multi-source data as guiding factors for calculating similarity, enabling the capture of more nuanced features. Subsequently, we integrate these features through a feature fusion process, where known associations between drugs and diseases act as guiding terms. This strategy allows us to uncover the complementary aspects of different viewpoints. Ultimately, we predict potential drug-disease associations using a multi-layer perceptron neural network. Our methodology has undergone rigorous testing through various cross-validation experiments and case studies. We are confident that FusionMVSA will prove to be a valuable tool in drug recommendation, offering new avenues for exploration and discovery in the quest to combat diseases.
- 22 May 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (11) , 8560-8571
GCNLA: Inferring Cell-Cell Interactions From Spatial Transcriptomics With Long Short-Term Memory and Graph Convolutional Networks
Spatial transcriptomics analysis methods offer an opportunity to investigate highly diverse biological tissues. Cell-cell communication is fundamental for maintaining physiological homeostasis in organisms and coordinating complex biological processes. Identifying cell-cell interactions is critical for understanding cellular activities. The interaction of a cell with other cells depends on several factors, and most of the existing methods that consider only gene expression information of neighbouring cells and spatial location information are somewhat limited. In this paper, we propose a network architecture based on graph convolution network and long short-term memory attention module-GCNLA, which contains graph convolution layer, long short-term memory network, attention module, and residual connections. GCNLA not only learns the spatial structure of cells but also captures interaction information between distal cells, the attention module further extracting and enhancing features related to cell-cell interactions. Finally, the inner product decoding calculates the cosine similarity, which is used to infer cell-cell interactions. In addition, GCNLA is capable of reconstructing the complete cell-cell interaction network. The experimental results on seqFISH and MERFISH demonstrate that the GCNLA network structure has better robustness and noise immunity. The potential features learned by GCNLA enable other downstream analyses, including single-cell resolution cell clustering based on spatial information resolving cell heterogeneity.
- 22 May 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 29 (11) , 8560-8571
GCNLA: Inferring Cell-Cell Interactions From Spatial Transcriptomics With Long Short-Term Memory and Graph Convolutional Networks
Spatial transcriptomics analysis methods offer an opportunity to investigate highly diverse biological tissues. Cell-cell communication is fundamental for maintaining physiological homeostasis in organisms and coordinating complex biological processes. Identifying cell-cell interactions is critical for understanding cellular activities. The interaction of a cell with other cells depends on several factors, and most of the existing methods that consider only gene expression information of neighbouring cells and spatial location information are somewhat limited. In this paper, we propose a network architecture based on graph convolution network and long short-term memory attention module-GCNLA, which contains graph convolution layer, long short-term memory network, attention module, and residual connections. GCNLA not only learns the spatial structure of cells but also captures interaction information between distal cells, the attention module further extracting and enhancing features related to cell-cell interactions. Finally, the inner product decoding calculates the cosine similarity, which is used to infer cell-cell interactions. In addition, GCNLA is capable of reconstructing the complete cell-cell interaction network. The experimental results on seqFISH and MERFISH demonstrate that the GCNLA network structure has better robustness and noise immunity. The potential features learned by GCNLA enable other downstream analyses, including single-cell resolution cell clustering based on spatial information resolving cell heterogeneity.
- 4 March 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 22 (3) , 1041-1051
ACP-ESM2: Enhancing Anticancer Peptide Prediction With Pre-Trained Protein Language Models
Anticancer peptide (ACP) are short peptides with anti-cancer properties that have generated increasing attention in recent years due to their low toxicity, minimal side effects, and their ability to precisely target and kill cancer cells. Traditionally, identifying ACP has relied on experimental methods, which are time-consuming and labor-intensive. While deep learning-based prediction methods have made significant progress, there is still room for improvement in achieving optimal performance. In this study, we present ACP-ESM2, a deep learning framework based on the Evolutionary Scale Modeling 2 (ESM2) pre-trained model, which captures rich evolutionary information from protein sequences. By combining ESM2 with convolutional neural network (CNN) that excels at detecting local patterns, ACP-ESM2 offers a highly accurate tool for ACP prediction. The experimental results indicate that ACP-ESM2 shows significant improvements over best-existing recognition techniques on the Test1 set, with enhancements of 2.3%, 7.2%, 12.6%, and 5% in ACC, SN, SP, and MCC, respectively. Notably, on the Test2 set, ACP-ESM2 achieves an accuracy of 97.6%, showcasing its exceptional robustness. This establishes ACP-ESM2 as an efficient and precise tool for predicting anticancer peptides. To facilitate predictions for researchers, we have set up a web server for ACP-ESM2, which is available at http://www.bioailab.com/ACP-ESM2.
- 4 March 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Computational Biology and Bioinformatics
- Vol. 22 (3) , 1041-1051
ACP-ESM2: Enhancing Anticancer Peptide Prediction With Pre-Trained Protein Language Models
Anticancer peptide (ACP) are short peptides with anti-cancer properties that have generated increasing attention in recent years due to their low toxicity, minimal side effects, and their ability to precisely target and kill cancer cells. Traditionally, identifying ACP has relied on experimental methods, which are time-consuming and labor-intensive. While deep learning-based prediction methods have made significant progress, there is still room for improvement in achieving optimal performance. In this study, we present ACP-ESM2, a deep learning framework based on the Evolutionary Scale Modeling 2 (ESM2) pre-trained model, which captures rich evolutionary information from protein sequences. By combining ESM2 with convolutional neural network (CNN) that excels at detecting local patterns, ACP-ESM2 offers a highly accurate tool for ACP prediction. The experimental results indicate that ACP-ESM2 shows significant improvements over best-existing recognition techniques on the Test1 set, with enhancements of 2.3%, 7.2%, 12.6%, and 5% in ACC, SN, SP, and MCC, respectively. Notably, on the Test2 set, ACP-ESM2 achieves an accuracy of 97.6%, showcasing its exceptional robustness. This establishes ACP-ESM2 as an efficient and precise tool for predicting anticancer peptides. To facilitate predictions for researchers, we have set up a web server for ACP-ESM2, which is available at http://www.bioailab.com/ACP-ESM2.